GOLDMAN SACHS GROUP INC - AADI BIOSCIENCE INC ownership

AADI BIOSCIENCE INC's ticker is and the CUSIP is 00032Q104. A total of 67 filers reported holding AADI BIOSCIENCE INC in Q2 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.8%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of AADI BIOSCIENCE INC
ValueSharesWeighting
Q2 2023$172,471
-3.5%
25,215
+2.1%
0.00%
Q1 2023$178,799
-49.0%
24,696
-9.7%
0.00%
Q4 2022$350,759
-3.6%
27,339
+6.1%
0.00%
Q3 2022$364,000
-32.3%
25,776
-41.0%
0.00%
Q2 2022$538,000
-46.8%
43,662
-26.7%
0.00%
Q1 2022$1,011,00059,5470.00%
Other shareholders
AADI BIOSCIENCE INC shareholders Q2 2023
NameSharesValueWeighting ↓
ABG Innovation Capital Partners III GP Ltd 26,666$377,00025.56%
Alerce Investment Management, L.P. 1,294,785$18,295,00017.62%
ACUTA CAPITAL PARTNERS, LLC 1,849,402$26,132,00011.25%
Decheng Capital Management III (Cayman), LLC 526,329$7,437,0002.70%
Ally Bridge Group (NY) LLC 124,625$1,761,0001.16%
Vivo Capital, LLC 509,572$7,200,0000.80%
Ghost Tree Capital, LLC 200,000$2,826,0000.79%
Avoro Capital Advisors LLC 2,849,402$40,262,0000.74%
BVF INC/IL 879,085$12,421,0000.51%
Knott David M Jr 49,039$693,0000.29%
View complete list of AADI BIOSCIENCE INC shareholders